Biomedical Research Unit Zacatecas, Mexican Institute for Social Security-IMSS, Zacatecas, Mexico.
Front Immunol. 2023 May 17;14:1194923. doi: 10.3389/fimmu.2023.1194923. eCollection 2023.
(Mtb) is one of the most important infectious agents worldwide and causes more than 1.5 million deaths annually. To make matters worse, the drug resistance among Mtb strains has risen substantially in the last few decades. Nowadays, it is not uncommon to find patients infected with Mtb strains that are virtually resistant to all antibiotics, which has led to the urgent search for new molecules and therapies. Over previous decades, several studies have demonstrated the efficiency of antimicrobial peptides to eliminate even multidrug-resistant bacteria, making them outstanding candidates to counterattack this growing health problem. Nevertheless, the complexity of the Mtb cell wall makes us wonder whether antimicrobial peptides can effectively kill this persistent Mycobacterium. In the present review, we explore the complexity of the Mtb cell wall and analyze the effectiveness of antimicrobial peptides to eliminate the bacilli.
结核分枝杆菌(Mtb)是全球最重要的传染病病原体之一,每年导致超过 150 万人死亡。更糟糕的是,过去几十年中结核分枝杆菌菌株的耐药性大幅上升。如今,发现几乎对所有抗生素都具有耐药性的结核分枝杆菌菌株感染的患者并不罕见,这导致人们迫切需要寻找新的分子和疗法。过去几十年的多项研究表明,抗菌肽能够有效消除甚至是多重耐药菌,使其成为对抗这一日益严重的健康问题的杰出候选药物。然而,结核分枝杆菌细胞壁的复杂性使我们怀疑抗菌肽是否能有效地杀死这种顽固的分枝杆菌。在本次综述中,我们探讨了结核分枝杆菌细胞壁的复杂性,并分析了抗菌肽消除杆菌的有效性。